x
0

Celgene Corporation (CELG)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Celgene's earnings

Delivery

Website notifications

Mobile App notifications

Add to/Remove from a Portfolio My Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
117.52 +1.81    +1.56%
16:56:33 GMT - Real-time CFD Data. Currency in USD ( Disclaimer )
Type: Equity
Market: United States
ISIN: US1510201049 
CUSIP: 151020104
  • Volume: 2,332,595
  • Bid/Ask: 117.51 / 117.52
  • Day's Range: 115.50 - 117.95
Start Trading
Celgene 117.52 +1.81 +1.56%

CELG Overview

 
Information about the Celgene Corporation Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close115.71
Day's Range115.5 - 117.95
Revenue11.68B
Open115.9
52 wk Range94.42 - 127.64
EPS2.65
Volume2,332,595
Market Cap90.35B
Dividend (Yield)0 (N/A)
Average Vol. (3m)4,339,228
P/E Ratio43.58
Beta1.84
1-Year Change14.04%
Shares Outstanding780,824,335
Next Earnings DateN/A

Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Buy Buy Neutral Sell Buy
Technical Indicators Strong Sell Strong Buy Strong Buy Strong Sell Strong Buy
Summary Neutral Strong Buy Buy Strong Sell Strong Buy

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Engulfing Bearish 15 Current
Engulfing Bearish 30 Current
Bullish Hammer 1W Current
Harami Bullish 1W Current
Completed Patterns
Evening Doji Star 1M 1 Apr 17
Upside Gap Two Crows 1M 1 Apr 17
Doji Star Bearish 1M 2 Mar 17

Celgene Corporation News & Analysis

Celgene Corporation Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NASDAQ 117.52 117.51 117.52 2,332,595 +1.56% USD 16:56:33  
  Mexico 2,171.00 0.00 0.00 0 0.00% MXN 22/05  
  Switzerland 113.10 113.00 114.30 60 -0.53% CHF 15:08:00  
  Switzerland 118.40 0.00 0.00 400 0.00% USD 13:57:00  
  TradeGate 105.34 104.89 105.09 1,194 +2.70% EUR 16:40:00  
  Munich 103.17 105.15 105.38 0 -1.12% EUR 06:04:00  
  Frankfurt 104.19 105.15 105.38 476 +1.62% EUR 15:05:00  
  Stuttgart 104.30 105.15 105.35 66 +1.71% EUR 15:02:00  
  Xetra 104.30 103.95 104.30 561 +2.81% EUR 15:14:00  
  Berlin 102.58 105.11 105.33 80 +0.57% EUR 07:21:00  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery

Website notifications

Mobile App notifications

  Name Last High Low Chg. Chg. % Vol. Time
  Apple 153.49 154.90 153.31 -0.50 -0.32% 11.87M 16:56:27  
  Tata Motors ADR 37.28 37.62 36.40 +2.38 +6.82% 1.37M 16:56:14  
  Amazon.com 968.29 975.00 966.98 -2.38 -0.25% 1.52M 16:56:25  
  Tesla 306.29 310.73 306.08 -4.06 -1.31% 2.11M 16:56:25  
  AMD 10.710 11.055 10.620 -0.330 -2.99% 34.56M 16:56:20  
  Alphabet 965.00 974.50 964.74 +0.93 +0.10% 970.73K 16:56:25  
  Alibaba 123.23 125.67 122.92 -1.52 -1.22% 8.61M 16:56:21  
  NVIDIA 135.92 139.79 135.88 -2.98 -2.15% 12.25M 16:56:29  
  Facebook 147.36 148.80 147.25 -0.88 -0.60% 8.10M 16:56:29  
  Nokia ADR 6.515 6.650 6.480 +0.305 +4.91% 29.38M 16:56:34  

Celgene Corporation Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

7132

Equity Type

ORD

Celgene Corporation is an integrated global biopharmaceutical company. The Company, together with its subsidiaries, is engaged in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases through solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation. Its commercial-stage products include REVLIMID (lenalidomide), POMALYST/IMNOVID (pomalidomide), OTEZLA (apremilast), ABRAXANE (paclitaxel albumin-bound particles for injectable suspension), VIDAZA, azacitidine for injection (generic version of VIDAZA) and THALOMID (thalidomide). Its clinical trial activity includes trials across the disease areas of hematology, solid tumors, and inflammation and immunology. The Company also markets ISTODAX, which is an epigenetic modifier. The Company is also evaluating AG-221 (enasidenib) in combination with VIDAZA in newly diagnosed acute myeloid leukemia with isocitrate dehydrogenase-2 mutations.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
U.S. Commodity Futures Trading Commission (United States) $250 Start Trading
Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States) $1000 Start Trading
No Start Trading

My Sentiments

Add your sentiment:
or
 
Members' Sentiments:
Bullish
50%
Bearish
50%

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post
Post also to:
1000
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post 1000
Please wait a minute before you try to comment again.
 
 
 
Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Add Chart to Comment
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.